examin
outcom
viral
encephalomyel
mous
hepat
viru
mhv
theiler
encephalomyel
viru
coxsackieviru
mice
autoantibodi
central
nervou
system
cn
specif
antigen
myelin
oligodendrocyt
glycoprotein
usual
develop
clinic
diseas
morbid
mortal
acut
viral
cn
diseas
augment
presenc
autoantibodi
three
viral
infect
transfer
serum
contain
autoantibodi
time
infect
mhv
suffici
reproduc
exacerb
diseas
presenc
autoantibodi
found
result
increas
infiltr
mononuclear
cell
brain
earli
demyelin
sever
augment
brain
spinal
cord
mhvinfect
mice
cnsspecif
autoantibodi
antibodymedi
exacerb
shown
independ
complement
system
requir
express
fc
receptor
observ
fc
receptordefici
mice
studi
illustr
possibl
infect
lead
much
profound
immunopatholog
presenc
otherwis
latent
autoimmun
condit
j
pathol
well
establish
anim
model
infecti
organ
trigger
augment
immun
respons
selfantigen
mechan
molecular
mimicri
bystand
activ
see
review
howev
autoimmun
alway
result
clinic
appar
diseas
cumul
infect
unrel
agent
may
requir
unmask
preexist
autoimmun
process
convers
viral
infect
could
take
worsen
cours
autoimmunepron
individu
shown
infect
provok
relaps
worsen
autoimmun
condit
anim
model
consist
report
show
common
infect
augment
risk
sever
relaps
multipl
sclerosi
ms
patient
aforement
anim
report
studi
tcellmedi
autoimmun
respons
autoantibodi
also
import
pathogen
potenti
see
review
central
nervou
system
cn
autoantibodi
myelin
compon
myelin
oligodendrocyt
glycoprotein
mog
particular
play
damag
role
mogspecif
antibodi
shown
play
major
role
murin
model
ms
experiment
autoimmun
encephalomyel
eae
clearli
associ
demyelin
lesion
ms
patient
thu
like
mediat
patholog
least
subset
patient
lesion
present
antibodi
deposit
howev
presenc
antibodi
specif
mog
cn
antigen
detect
ms
patient
also
healthi
subject
albeit
lower
frequenc
thu
like
addit
trigger
may
requir
diseas
develop
litzenburg
et
al
previous
demonstr
transgen
mice
rearrang
vdj
region
mogspecif
monoclon
antibodi
h
chain
replac
germlin
j
h
locu
antimog
immunoglobulin
ig
knockin
mice
also
refer
th
mog
mice
present
report
exhibit
exacerb
form
eae
howev
without
addit
autoantigen
immun
th
mog
mice
develop
spontan
clinic
diseas
despit
presenc
autoreact
b
cell
releas
mogspecif
igg
igm
serum
transgen
b
cell
th
mog
undergo
normal
differenti
matur
autoantibodi
differ
class
subclass
membraneassoci
secret
gener
thu
possibl
interact
autoreact
ig
effector
immun
system
occur
mice
therefor
constitut
good
model
evalu
hypothesi
viral
infect
cn
would
lead
worsen
immunopatholog
diseas
superimpos
underli
humor
autoimmun
condit
neurotrop
strain
murin
coronavirus
mous
hepat
viru
mhv
mhv
jhm
relat
mutant
provid
inform
model
pathogenesi
virusinduc
enceph
demyelin
see
review
mice
infect
mhv
typic
undergo
brief
period
acut
encephalomyel
follow
extend
period
chronic
demyelin
acut
phase
infect
viru
found
astrocyt
oligodendrocyt
neuron
cell
respons
initi
control
infect
antibodi
requir
complet
clearanc
viru
prevent
reemerg
second
phase
diseas
macrophag
also
cell
shown
mediat
demyelin
report
intracrani
infect
th
mog
mice
mhv
result
acceler
kinet
onset
sever
clinic
diseas
increas
death
th
mog
compar
wildtyp
mice
exacerb
cn
diseas
shown
transfer
autoantibodi
observ
model
viral
enceph
well
immunohistochem
examin
brain
section
fluorescenceactiv
cell
sort
analysi
infiltr
cell
brain
show
overal
increas
number
mononuclear
cell
demyelin
found
augment
brain
spinal
cord
mice
antimog
antibodi
fc
receptordefici
mice
shown
protect
autoantibodymedi
enhanc
patholog
indic
mechan
exacerb
involv
fcmediat
effect
thu
autoantibodi
specif
antigen
immunolog
privileg
cn
combin
local
viral
induc
inflamm
tissu
destruct
lead
increas
sensit
diseas
mice
th
mog
mice
encod
rearrang
cdna
pathogen
mogspecif
monoclon
antibodi
place
germlin
j
h
locu
result
mogbind
ig
surfac
express
onethird
b
cell
undergo
normal
classswitch
secret
affin
matur
encount
antigen
mous
hepat
virusattenu
neurotrop
isol
grown
delay
brain
tumor
dbt
cell
theiler
murin
encephalomyel
viru
tmev
daniel
strain
obtain
dr
mcgavern
scripp
research
institut
grown
cell
viral
titer
determin
plaqu
assay
dbt
cell
coxsackieviru
grown
titer
previous
describ
pichind
viru
stock
grown
titrat
vero
cell
isofluraneanesthet
mice
inocul
l
contain
viru
dilut
steril
phosphatebuff
salin
pb
use
needl
penetr
cranium
later
midlin
sign
clinic
cn
diseas
monitor
daili
score
use
standard
describ
figur
serum
th
mog
mice
obtain
retroorbit
bleed
cardiac
punctur
pool
use
transfer
experi
recipi
anim
receiv
l
serum
pool
intraperiton
time
viral
infect
wherea
control
receiv
volum
normal
mous
serum
later
repeat
experi
pb
normal
serum
found
measur
effect
cours
infect
mice
euthan
overdos
chloral
hydrat
dilut
salin
perfus
ml
formalin
fixat
overnight
brain
spinal
cord
paraffinembed
section
stain
hematoxylin
eosin
h
e
evalu
infiltr
luxol
fast
blue
demyelin
brain
pbsperfus
mice
mechan
disrupt
frost
slide
lipid
compon
debri
remov
collagenas
sigma
treatment
centrifug
percol
sigma
brain
group
five
six
mice
pool
obtain
enough
mononuclear
cell
assay
fc
receptor
block
ebiosci
san
diego
ca
cell
stain
antibodi
directli
coupl
fluorochrom
data
acquir
bd
facscalibur
macrophagesmicroglia
cell
type
cell
gate
analyz
express
specif
marker
antibodi
obtain
ebiosci
signific
evalu
use
mannwhitney
daybyday
differ
clinic
score
viral
titer
ratio
area
affect
demyelin
fisher
exact
test
incid
diseas
autoimmun
mice
none
control
group
logrank
surviv
differ
mortal
entir
experi
test
use
graphpadinstat
softwar
th
mog
mice
infect
three
increas
dose
mhv
strain
typic
symptom
enceph
observ
group
viral
dose
howev
clinic
sign
cn
diseas
occur
earlier
stronger
th
mog
mice
compar
control
figur
top
three
viral
dose
also
result
increas
death
rate
th
mog
mice
comparison
control
figur
bottom
rule
enhanc
diseas
observ
transgen
mice
could
caus
absenc
function
antibodi
repertoir
possibl
genet
defect
first
examin
outcom
cn
infect
mhv
heterozyg
th
mog
mice
obtain
backcross
transgen
mice
parent
strain
acut
enceph
also
exacerb
mice
compar
control
figur
indic
aggrav
diseas
probabl
due
presenc
cnsspecif
b
cell
autoantibodi
examin
whether
transgen
b
cell
autoantibodi
respons
increas
cn
diseas
first
transfer
purifi
th
mog
b
cell
wt
mice
observ
exacerb
cn
diseas
compar
control
receiv
wildtyp
b
cell
although
much
lesser
extent
origin
th
mog
anim
data
shown
howev
serum
uninfect
th
mog
mice
transfer
wildtyp
recipi
time
infect
mhv
exacerb
cn
diseas
similar
level
found
mhvinfect
th
mog
mice
observ
figur
addit
transfer
proteina
purifi
antibodi
serum
th
mog
result
compar
exacerb
mhvinduc
enceph
serum
data
shown
studi
clearli
map
caus
enhanc
viral
induc
cn
diseas
th
mog
mice
antimog
autoantibodi
test
effect
presenc
antimog
antibodi
nonleth
viral
model
cn
infect
determin
whether
virus
differ
famili
differ
degre
pathogen
could
exacerb
presenc
antimog
autoantibodi
although
differ
observ
clinic
silent
enceph
induc
plaqueform
unit
pfu
pichind
viru
exacerb
cn
diseas
autoantibodi
observ
mice
infect
tmev
cv
tabl
genet
resist
tmev
infect
ie
viru
replic
caus
detect
inflamm
demyelin
expect
behavior
sign
acut
cn
diseas
seen
control
mice
howev
th
mog
heterozyg
anim
develop
clinic
evid
diseas
onehalf
sick
anim
die
within
week
tabl
likewis
sign
diseas
could
observ
control
pup
infect
pfu
cv
wherea
heterozyg
autoimmun
mice
becam
sick
respect
tabl
reflect
profound
differ
weight
two
group
inject
pfu
cv
pup
initi
gain
weight
equal
rate
th
mog
versu
control
day
infect
transgen
anim
start
grow
slower
rate
eventu
lost
weight
result
averag
start
weight
day
infect
versu
control
p
mannwhitney
test
experi
show
advers
effect
preexist
autoantibodi
impact
outcom
varieti
viral
enceph
also
show
exacerb
occur
larg
spectrum
clinic
manifest
enceph
autoantibodi
transform
clinic
silent
infect
symptomat
diseas
tmev
cv
transform
mild
cn
patholog
lethal
one
mhv
pfu
acceler
clinic
cours
mhv
pfu
test
whether
viral
replic
requir
trigger
diseas
mice
cn
autoantibodi
inject
pfu
equival
uvinactiv
mhv
caus
detect
clinic
diseas
homozyg
th
mog
mice
period
n
data
shown
likewis
sign
clinic
diseas
detect
mice
infect
pfu
mhv
via
intraperiton
rout
n
data
shown
dose
result
clinic
silent
hepat
activ
viral
replic
week
mice
rb
mjb
person
observ
thu
neither
disrupt
blood
brain
barrier
viral
antigen
cn
infect
peripher
organ
elicit
enhanc
immunopatholog
th
mog
mice
show
activ
viral
replic
cn
requir
viral
titer
brain
control
mice
mice
autoantibodi
th
mog
homoand
heterozyg
mice
recipi
antimog
serum
compar
differ
time
point
signific
differ
found
titer
mice
autoantibodi
compar
control
day
data
shown
day
figur
infect
indic
viru
replic
initi
similar
rate
anim
howev
although
titer
start
decreas
group
day
reduct
viral
load
less
pronounc
mice
antimog
autoantibodi
compar
control
figur
thu
abil
control
viral
cn
infect
slightli
impair
presenc
cn
autoantibodi
exclud
system
defect
cytotox
immun
respons
mhv
mogig
mice
compar
frequenc
virusspecif
cell
spleen
control
recipi
antimog
serum
enzymelink
immunospot
elispot
assay
perform
describ
previous
found
signific
differ
frequenc
purifi
cell
respond
immunodomin
mhv
epitop
locat
viral
envelop
protein
day
infect
data
shown
thu
autoantibodi
alter
system
antivir
cytotox
immun
respons
studi
mechan
respons
autoantibodymedi
augment
viral
enceph
chose
model
result
sever
outcom
major
autoimmun
mice
spare
control
anim
follow
experi
thu
perform
pfu
mhv
h
estain
brain
spinal
cord
section
obtain
control
mice
autoantibodi
examin
presenc
infiltr
cell
degre
infiltr
appear
augment
mice
autoantibodi
compar
control
anim
day
infect
frequenc
perivascular
cuf
number
infiltr
cell
within
inflamm
area
higher
mice
autoantibodi
compar
control
figur
ae
morpholog
infiltr
appear
compos
mix
inflammatori
cell
popul
numer
neutrophil
seen
control
mice
autoantibodi
figur
fg
determin
precis
natur
infiltr
cell
perform
flow
cytometri
experi
mononuclear
cell
purifi
infect
brain
enumer
purifi
cell
individu
brain
confirm
increas
cellular
brain
mice
autoantibodi
figur
presenc
autoantibodi
result
signific
differ
number
b
lymphocyt
figur
contrari
frequenc
nk
cell
bloodborn
macrophag
somewhat
elev
mice
autoantibodi
figur
altogeth
result
show
brain
infiltr
lymphocyt
particular
cell
bear
fc
receptor
augment
presenc
antimog
antibodi
mhv
enceph
mhv
antimog
antibodi
eae
model
provok
demyelin
evalu
eventu
addit
effect
joint
presenc
cn
examin
section
brain
spinal
cord
mhvinfect
autoimmun
control
mice
presenc
demyelin
lesion
day
infect
vast
major
demyelin
area
found
central
white
matter
cerebellum
brainstem
region
surround
third
ventricl
control
mice
autoantibodi
extent
lesion
found
augment
latter
group
wildtyp
mice
brain
small
lesion
detect
major
anim
investig
possibl
involv
differ
effector
associ
demyelin
cn
patholog
model
compar
outcom
cn
infect
mhv
presenc
absenc
antimog
antibodi
differ
ko
mous
model
absenc
either
cell
control
mhv
infect
cn
impair
mortal
found
much
higher
control
group
ko
mice
observ
wt
mice
howev
exacerb
diseas
presenc
autoantibodi
still
observ
absenc
n
collect
day
mhv
infect
mononuclear
cell
purifi
individu
brain
count
pool
group
stain
flow
cytometri
analysi
graph
show
averag
number
lymphocyt
b
lymphocyt
nk
cell
neutrophil
bloodborn
macrophag
high
resid
microglia
low
per
anim
similar
result
obtain
addit
independ
experi
perform
day
infect
clinic
data
shown
surviv
tabl
level
likewis
exacerb
cn
diseas
still
evid
absenc
function
complement
system
ko
mice
tabl
last
mice
defici
ino
control
surviv
wherea
mice
transfer
antimog
serum
succumb
infect
tabl
result
show
neither
cell
cell
complement
ino
alon
respons
autoantibodymedi
patholog
determin
whether
pathogen
effect
autoantibodi
requir
fc
receptor
compar
outcom
viral
enceph
presenc
absenc
cnsspecif
autoantibodi
mice
defici
fc
receptor
fcr
shown
figur
clinic
statu
group
found
similar
wherea
mhv
wildtyp
mice
show
expect
exacerb
transfer
serum
pool
experi
fc
receptordefici
mice
repeat
two
mice
per
group
absenc
exacerb
confirm
day
infect
clinic
score
versu
control
mice
transfer
autoimmun
serum
respect
anim
sacrif
obtain
histolog
data
section
brain
spinal
cord
show
differ
level
infiltr
demyelin
control
recipi
antimog
serum
data
shown
experi
clearli
demonstr
cell
bear
fc
receptor
involv
augment
morbid
mortal
observ
mhvinfect
mice
presenc
antimog
antibodi
show
moder
cn
diseas
infect
mous
cn
mhv
dramat
aggrav
preexist
humor
autoimmun
respons
cn
antigen
mog
find
limit
singl
viru
found
tmev
cv
use
condit
control
anim
develop
diseas
also
trigger
patholog
mice
autoantibodi
three
virus
low
genet
relat
indic
mechan
respons
augment
diseas
unlik
involv
crossreact
selfantigen
pathogen
like
inflammatori
milieu
gener
infect
allow
entri
autoantibodi
otherwis
seclud
cn
compart
attract
immun
mediat
contribut
immunopatholog
found
infiltr
mononuclear
cell
brain
mhv
infect
augment
presenc
autoantibodi
affect
infiltr
cell
type
particular
augment
frequenc
neutrophil
bloodborn
macrophag
detect
recipi
antimog
serum
transfer
heterozyg
th
mog
mice
compar
control
antimog
antibodi
particular
shown
augment
demyelin
eae
model
likewis
shown
incid
intens
earli
demyelin
augment
brain
spinal
cord
mice
antimog
autoantibodi
local
area
affect
brain
found
similar
control
mice
anim
autoantibodi
interestingli
similar
pattern
describ
experi
perform
transfus
mogspecif
monoclon
antibodi
along
mogspecif
cell
rat
histopatholog
pattern
reminisc
multifoc
lesion
throughout
brain
spinal
cord
found
eae
anim
model
acut
dissemin
encephalomyel
human
result
show
neither
cell
alon
respons
aggrav
diseas
although
tcell
subset
shown
import
effector
respons
demyelin
cn
infect
mhv
increas
patholog
observ
autoimmun
mice
viral
infect
thu
result
distinct
autoantibodymedi
mechan
rather
exacerb
damag
caus
directli
viru
antivir
immun
respons
augment
diseas
transfer
serum
contain
autoantibodi
fc
receptormedi
support
hypothesi
viral
replic
similar
control
mice
autoantibodi
first
day
infect
significantli
higher
autoimmun
mice
day
infect
elispot
intracellular
cytokin
data
indic
howev
viralspecif
cytotox
respons
significantli
impair
mice
neither
system
local
level
complement
deposit
found
lesion
ms
patient
demyelin
potenti
myelinspecif
antibodi
shown
correl
complementbind
abil
experi
perform
ko
mice
indic
model
complement
littl
involv
autoantibodymedi
patholog
anoth
possibl
sourc
cn
damag
shown
involv
ms
lesion
howev
play
littl
role
mhvinduc
demyelin
even
though
damag
neuron
infect
inosdefici
mice
report
better
surviv
rate
wildtyp
anim
accord
literatur
found
control
ino
ko
mice
surviv
infect
better
anim
howev
experi
show
ino
involv
antibodymedi
patholog
ko
mice
transfus
autoimmun
serum
succumb
infect
contrari
found
defici
cellular
fc
receptor
suffici
abrog
complet
autoantibodymedi
patholog
clinic
histolog
level
indic
neutrophil
macrophag
nk
cell
respons
autoantibodymedi
patholog
base
result
characterist
mononuclear
infiltr
autoimmun
mice
propos
cell
monocytemacrophagemicroglia
lineag
neutrophil
nk
cell
respons
autoantibodi
gener
damag
mechan
involv
complement
ino
releas
exist
crossreact
antibodi
bind
viral
selfantigen
extens
investig
report
knowledg
focus
vivo
interplay
noncrossreact
autoantibodi
viral
infect
shown
provok
relaps
experiment
autoimmun
arthriti
mice
lactat
dehydrogenaseelev
viru
mhv
result
dramat
exacerb
patholog
mortal
mous
model
antibodytrigg
autoimmun
hemolyt
anemia
likewis
lactat
dehydrogenaseelev
viru
mhv
infect
also
provok
sever
thrombocytopenia
mice
treat
antiplatelet
antibodi
otherwis
nonpathogen
dose
knowledg
present
report
constitut
first
descript
similar
phenomenon
cn
compart
anim
model
find
consist
previou
studi
perform
human
patient
suggest
correl
presenc
autoantibodi
cerebrospin
fluid
csf
outcom
enceph
desai
et
al
report
fatal
outcom
cohort
patient
japanes
enceph
viru
infect
significantli
associ
presenc
csf
autoantibodi
neurofila
protein
particular
likewis
matsui
et
al
found
group
patient
viral
enceph
undefin
etiolog
three
four
patient
cn
autoantibodi
among
total
five
individu
unfavor
outcom
studi
perform
patient
enrol
time
patholog
declar
make
imposs
determin
whether
autoantibodi
exist
cn
infect
appear
consequ
enceph
likewis
way
determin
whether
autoantibodi
direct
role
unfavor
outcom
mere
associ
marker
howev
view
result
obtain
present
studi
possibl
autoimmun
statu
patient
advers
effect
evolut
cn
diseas
conclus
studi
strengthen
hypothesi
individu
preexist
autoantibodi
without
clinic
autoimmun
diseas
certain
virus
heighten
pathogen
potenti
reinforc
concept
pathogen
unrel
initi
develop
autoimmun
condit
may
caus
exacerb
episod
modifi
local
system
environ
model
autoimmun
fertil
field
propos
autoreact
cell
first
gener
infect
molecular
mimicri
bystand
mechan
may
remain
nonpathogen
extend
period
unrel
virus
bacteria
may
respons
trigger
actual
autoimmun
patholog
model
koch
postul
one
diseaseon
pathogen
strictli
respect
may
explain
difficult
associ
singl
organ
given
autoimmun
diseas
